Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEX Biometrics ASA AGM Information 2018

May 9, 2018

3633_rns_2018-05-09_62107479-d5d1-4e04-b870-fdc51b968e49.html

AGM Information

Open in viewer

Opens in your device viewer

Annual general meeting in IDEX held on 9 May 2018

Annual general meeting in IDEX held on 9 May 2018

Oslo, Norway - 9 May 2018 - IDEX ASA, held its annual general meeting on 9 May

All resolutions were made in accordance with the proposals by the board and the

nomination committee in the notice calling the meeting, issued on 18 April 2018

and 8 May 2018.

Mr Morten Opstad continues as chairman of the Board for the second year of his

term, while Ms Deborah Davis, Ms Hanne Høvding and Mr Lawrence John Ciaccia

continue as board members for their second year of their terms. Mr Andrew James

MacLeod was re-elected as board member for a period of two years. Following the

annual general meeting, the board consists of chairman Morten Opstad, and board

members Larry Ciaccia, Deborah Davis, Hanne Høvding and Andy MacLeod.

The members of the nomination committee continues for the second year of their

term. The nomination committee consists of chairman Harald Voigt and members

Robert N. Keith and Rune Sundvall.

Contact:

Charlotte Knudsen, Director of IR and Communications,

+47 9756 1959, [email protected]

About IDEX ASA:

IDEX is a leading developer of advanced off-chip fingerprint sensors and

complete system solutions to a range of biometrically-enabled applications,

including smart cards, Internet of Things (IoT) and mobile. The company's

technology is based on a fundamentally unique architecture that delivers form

factor flexibility and superior cost-performance characteristics. IDEX's total

addressable market represents a fast-growing multi-billion unit opportunity.

IDEX ASA is traded on the Oslo stock exchange under the ticker IDEX.

For more information, please visit www.idexbiometrics.com and follow us on

Twitter @IDEXASA

This information is subject to the disclosure requirements pursuant to section

5-12 of the Norwegian Securities Trading Act.